Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples